🔎 Trials Near Me

Home › Prostate Cancer › California › Sacramento

Prostate Cancer clinical trials in Sacramento, CA

19 studies for Prostate Cancer are looking for participants at sites in and around Sacramento (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

RecruitingPhase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT06931340

Distance-Based Exercise to Preserve Function and Prevent Disability

Recruiting
  • Kaiser Permanente-South Sacramento, Sacramento
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07059884

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

RecruitingPhase 3
  • University of California Davis Comprehensive Cancer Center, Sacramento
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT07200830

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

RecruitingPhase 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06632977

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi away
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

RecruitingPhase 3
  • University of California Davis (UC Davis) Comprehensive Cancer Center ( Site 0114), Sacramento
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06136650

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

RecruitingPhase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
  • South Sacramento Cancer Center, Sacramento
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

RecruitingPhase 3
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi away
Ages 18 and older · Men · Updated Aug 19, 2026 · NCT04423211

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

RecruitingPhase 2
  • University of California Davis, Sacramento
Ages 18 and older · Men · Updated Aug 14, 2026 · NCT04812366

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

RecruitingPhase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Ages 18 to 100 · Men · Updated Aug 13, 2026 · NCT05519449

Comparison of New SUREcore Biopsy of Needle to Standard of Care During Transperineal Prostate Biopsies

Recruiting
  • UC Davis Departments of Urologic Oncology, Sacramento
Ages 18 and older · Men · Updated Aug 6, 2026 · NCT06907446

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

RecruitingPhase 3
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi away
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924

Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer

Recruiting
  • University of California Davis Comprehensive Cancer Center, Sacramento
Ages 18 and older · Men · Updated Jun 30, 2026 · NCT06178354

Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)

Recruiting
  • University of California, Davis, Sacramento
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT06101290

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

RecruitingPhase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Kaiser Permanente-South Sacramento, Sacramento
Ages 18 and older · Men · Updated Apr 14, 2026 · NCT06235697

Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer

RecruitingPhase 2
  • University of California Davis Comprehensive Cancer Center, Sacramento
Ages 18 and older · Men · Updated Mar 13, 2026 · NCT06173362

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

RecruitingPhase 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT06778863

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

RecruitingPhase 2
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 mi away
Ages 18 and older · Men · Updated Jan 29, 2026 · NCT05806515

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

RecruitingPhase 3
  • Kaiser Permanente Downtown Commons, Sacramento
  • Mercy Cancer Center - Sacramento, Sacramento
  • University of California Davis Comprehensive Cancer Center, Sacramento
  • and 2 more
Ages 18 and older · Men · Updated Sep 11, 2025 · NCT03678025

About Prostate Cancer

Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.

More about Prostate Cancer on MedlinePlus

Prostate Cancer trials in other cities

Other studies in Sacramento

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.